Effects of Peanuts on Immunity and Cardiometabolic Risk Factors

Completed · Not applicable

Conditions studied: Immune Response, Cardiometabolic Risk Factors

In brief

The aim of the proposed study is two-fold: to determine whether the intake of peanuts (a) enhances immune function and (b) produces a desirable impact on selected cardiometabolic biomarkers and risk factors.

Key facts

Study ID

NCT06159556

Run by

Loma Linda University

People needed

80

Starts

2024-01-31

Expected to finish

2024-09-26

Last updated by the study team

2024-10-02

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• adults between the ages of 18-70 years

You may not qualify if…

• known intolerance or allergy to peanuts
• bad dentures unable to chew peanuts
• regular intake of peanuts and/or other nuts (>3 ounces/week)
• use of immune-boosting supplements
• exposure to antibiotics and corticoids immediately prior to the study
• use of other medications or supplements that can interfere with the immune functions
• Individuals that received any vaccination (i.e flu or Covid 19) 6 months prior to the start of the study

Where it is running

• Loma Linda University School of Public Health — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.